SecBot SecBot
Insider Buy ·Filed Jun 12, 2026

PRTA

PROTHENA CORP PUBLIC LTD CO
BULLISH
Impact 5/10
Horizonweeks Processed5mo ago SEC0001045463-26-000007
Insider cluster: 1 insiders, $1.5M total
Actionable Insight ▲ Bullish

The concentrated buying by the 10% owner signals strong internal conviction. Traders should watch for upcoming clinical catalysts (e.g., trial readouts or regulatory updates) that may have motivated the purchases. Consider building a position on further dips but monitor for any negative news.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.15
T+0 close · Jun 12, 2026 · via day close
Latest settled
+14.11%
T+60 · $9.30
Vs SPY
+13.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 15 $8.15entry
  2. T+1 · 5mo ago +1.72%α +2.31% · $8.29
  3. T+5 · 5mo ago +12.27%α +13.65% · $9.15
  4. T+20 · 4mo ago +8.34%α +9.09% · $8.83
  5. T+60 · 2mo ago +14.11%α +13.11% · $9.30
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

10% owner William P. Scully purchased $1.49M of Prothena stock in two open-market transactions from June 4-11, 2026, at prices between $8.17 and $9.31. This represents ~0.34% of the $432M market cap and is a notable insider conviction signal, especially as prior insider buys in the last 30 days totaled $2.9M. The purchase comes amid a 67% analyst bullish consensus and adds to a pattern of insider buying.

Key Financial Metrics

Direction
buying
Total Value
$1.5M
Insiders
1

Key Facts

  • William P. Scully (10% owner) bought 175,000 shares total for $1.49M
  • First trade: 50,000 shares at $9.31 on June 4; second: 125,000 shares at $8.17 on June 11
  • Market cap of $432M makes this ~0.34% of company value
  • Recent insider activity: 4 buys totaling $2.9M in the last 30 days
  • Analyst consensus: 67% bullish (8 Buy, 3 Hold, 1 Sell)

Financial Impact

$1.49M insider purchase by 10% owner, ~0.34% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Clinical-stage biotech binary risk: trial failures could erase gains
  • Single insider buy, even by a 10% owner, may not be replicated by other executives

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001045463-26-000007

Track record

20 reports on PRTA

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +5.90% at T+5 after the Oct 29, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
  3. Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
  4. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
  5. Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
  6. Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
  7. Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
  8. Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
  9. Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
  10. Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026